Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Sham-Controlled, Multi-Center, Double-Blind Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft to Supplement Nucleus Pulposus Tissue in Participants With Lumbar Discogenic Pain Associated With Degenerative Disc Disease

NCT06778447 is registered in ClinicalTrials.gov with VIVEX Biologics, Inc. as lead sponsor.

NCT NCT06778447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06778447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Sham-Controlled, Multi-Center, Double-Blind Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft to Supplement Nucleus Pulposus Tissue in Participants With Lumbar Discogenic Pain Associated With Degenerative Disc Disease
Lead sponsor
VIVEX Biologics, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
February 17, 2025
Completion date
October 31, 2028
Enrollment
325 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, disc degeneration, lumbar discogenic pain